Nomura Holdings
WST icon

Nomura Holdings’s West Pharmaceutical WST Stock Holding History

Nomura Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,200
Closed -$9.67M – 2424
2024
Q3 		$9.67M Sell
32,200
-7,800
-20% -$2.39M 0.02% 448
2024
Q2 		$13.2M Buy
+40,000
New +$14.1M 0.03% 377
2024
Q1 		– Sell
-35,000
Closed -$12.3M – 2074
2023
Q4 		$12.3M Buy
+35,000
New +$12.4M 0.03% 387

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nomura Holdings's WST Position: Q2 2026 in Review

Nomura Holdings opened a new position in West Pharmaceutical (WST) in Q2 2026: 7,972 shares worth $2.86M. The stake represents ﹤0.01% of the portfolio and ranks #979 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in WST as recently as Q4 2025.

Nomura Holdings first reported a position in WST in Q1 2014 and has held it in 33 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Nomura Holdings held 7,972 shares of West Pharmaceutical worth $2.86M as of Q2 2026.
  • West Pharmaceutical was a new Nomura Holdings position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #979 holding.
  • Nomura Holdings first reported a position in West Pharmaceutical in Q1 2014 and has held it in 33 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.